Skip to content

Topical Lidocaine for Needle Insertion and Injection Pain

Topical Lidocaine 2% Gel for Analgesia and Patient Comfort During Interscalene Brachial Plexus and Axillary Blocks: A Noninferiority Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03206320
Enrollment
30
Registered
2017-07-02
Start date
2016-12-05
Completion date
2019-10-31
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Needle Insertion and Injection Pain

Brief summary

Skin infiltration with local anesthetic is commonly used to decrease patient discomfort during peripheral nerve blocks. Topically applied local anesthetic gel might provide analgesia while eliminating the need for additional injections. The primary objective of this study was a noninferiority comparison between the analgesia achieved with topical gel with that of skin infiltration for pain upon needle insertion and injection during administration of the interscalene brachial (ISBP) and axillary (AX) plexus blocks.

Interventions

Comparison of lidocaine topical gel with lidocaine infiltration and with no local anesthesia in reducing needle insertion and injection pain

Sponsors

New York School of Regional Anesthesia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Ability to understand Dutch, French or English language, purpose and risks of the study, provide signed and dated informed consent and authorization to use protected health information (PHI) in accordance with national and local subject privacy regulations * Age \>18 at the time of informed consent * ASA I-III physical class * Scheduled for elective shoulder or upper arm surgery requiring a preoperative interscalene brachial (ISBP) or axillary (AX) plexus block

Exclusion criteria

* History of an allergy or contra-indication to a local anesthetic * Baseline neurological deficit * Medical condition that will make it difficult to assess sensory distribution or communicate with a staff member * Presence of preexisting coagulation disorders * Infection at injection site * Concomitant opioid therapy * Recent history (\<3 months) of drug or alcohol abuse * Female subjects who are pregnant or currently breastfeeding, or who have a positive pregnancy test result at first visit

Design outcomes

Primary

MeasureTime frameDescription
Needle insertion painImmediately at the time the needle is inserted through the skinPain rating (VAS)
Injection painImmediately at the end of the blockPain rating (VAS)

Secondary

MeasureTime frameDescription
FearfulnessJust before the nerve blockLikert scale from 1 (no fear) to 5 (very fearful)
Overall discomfortImmediately at the end of the blockVerbal rating scale from 0 (more comfortable/less painful than expected) to 10 (less comfortable/more painful than expected)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026